Cargando…

Emerging Therapies for Advanced Cholangiocarcinoma: An Updated Literature Review

Cholangiocarcinoma is a group of malignancies with poor prognosis. Treatments for the management of advanced-stage cholangiocarcinoma are limited, and the 5-year survival rate is estimated to be approximately 5–15%, considering all tumor stages. There is a significant unmet need for effective new tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vignone, Anthony, Biancaniello, Francesca, Casadio, Marco, Pesci, Ludovica, Cardinale, Vincenzo, Ridola, Lorenzo, Alvaro, Domenico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584870/ https://www.ncbi.nlm.nih.gov/pubmed/34768421 http://dx.doi.org/10.3390/jcm10214901

Ejemplares similares

Molecular Landscape and Therapeutic Strategies in Cholangiocarcinoma: An Integrated Translational Approach towards Precision Medicine
por: Casadio, Marco, et al.
Publicado: (2021)

Role of the Gut–Liver Axis in the Pathobiology of Cholangiopathies: Basic and Clinical Evidence
por: Bragazzi, Maria Consiglia, et al.
Publicado: (2023)

New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin
por: Bragazzi, Maria Consiglia, et al.
Publicado: (2018)

Hyaluronan-Based Grafting Strategies for Liver Stem Cell Therapy and Tracking Methods
por: Nevi, Lorenzo, et al.
Publicado: (2019)

Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System
por: Lamarca, Angela, et al.
Publicado: (2021)

The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies
por: Ridola, Lorenzo, et al.
Publicado: (2018)

Setup of multidisciplinary team discussions for patients with cholangiocarcinoma: current practice and recommendations from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
por: Casadio, M., et al.
Publicado: (2022)

First-line therapies for Helicobacter pylori eradication: a critical reappraisal of updated guidelines
por: De Francesco, Vincenzo, et al.
Publicado: (2017)

New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma
por: Massironi, Sara, et al.
Publicado: (2020)

Updates in Cholangiocarcinoma
por: O’Hagan, Kristen
Publicado: (2022)

Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids
por: Ruiz de Gauna, Mikel, et al.
Publicado: (2022)

Hepatic Encephalopathy in the 21st Century: Still an Emerging Topic
por: Ridola, Lorenzo, et al.
Publicado: (2021)

Update on Treatment Options for Advanced Bile Duct Tumours: Radioembolisation for Advanced Cholangiocarcinoma
por: Najran, Pavan, et al.
Publicado: (2017)

Periostin and mesothelin: Potential predictors of malignant progression in intrahepatic cholangiocarcinoma
por: Mandrekar, Pranoti, et al.
Publicado: (2018)

Matrisome analysis of intrahepatic cholangiocarcinoma unveils a peculiar cancer-associated extracellular matrix structure
por: Carpino, Guido, et al.
Publicado: (2019)

Newest Therapies for Cholangiocarcinoma: An Updated Overview of Approved Treatments with Transplant Oncology Vision
por: Zhang, Yuqi, et al.
Publicado: (2022)

First- and second-line Helicobacter pylori eradication with modified sequential therapy and modified levofloxacin-amoxicillin-based triple therapy
por: Zullo, Angelo, et al.
Publicado: (2014)

High-dose esomeprazole and amoxicillin dual therapy for first-line Helicobacter pylori eradication: a proof of concept study
por: Zullo, Angelo, et al.
Publicado: (2015)

Activation of Fas/FasL pathway and the role of c-FLIP in primary culture of human cholangiocarcinoma cells
por: Carnevale, Gianluca, et al.
Publicado: (2017)

Targeted Therapies in Advanced Cholangiocarcinoma
por: Storandt, Michael H., et al.
Publicado: (2023)

Emerging roles of long noncoding RNAs in cholangiocarcinoma: Advances and challenges
por: Yang, Yang, et al.
Publicado: (2020)

Current update on combined hepatocellular-cholangiocarcinoma
por: Maximin, Suresh, et al.
Publicado: (2014)

Artificial intelligence and cholangiocarcinoma: Updates and prospects
por: Haghbin, Hossein, et al.
Publicado: (2022)

Emerging molecular targets and therapy for cholangiocarcinoma
por: Kayhanian, Hamzeh, et al.
Publicado: (2017)

Neoadjuvant therapy in the treatment of hilar cholangiocarcinoma: Review of the literature
por: Frosio, Fabio, et al.
Publicado: (2019)

Novel Targeted Therapies for Advanced Cholangiocarcinoma
por: Rizzo, Alessandro, et al.
Publicado: (2021)

Update on the Genetics of and Systemic Therapy Options for Combined Hepatocellular Cholangiocarcinoma
por: Azizi, Alexander A., et al.
Publicado: (2020)

Advances in the management of cholangiocarcinoma
por: Zori, Andreas G, et al.
Publicado: (2021)

Sensitivity of Human Intrahepatic Cholangiocarcinoma Subtypes to Chemotherapeutics and Molecular Targeted Agents: A Study on Primary Cell Cultures
por: Fraveto, Alice, et al.
Publicado: (2015)

Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update
por: Roßner, Florian, et al.
Publicado: (2023)

Update of the Bologna Experience in Radioembolization of Intrahepatic cholangiocarcinoma
por: Mosconi, Cristina, et al.
Publicado: (2023)

Update on the risk factors for opisthorchiasis and cholangiocarcinoma in Thailand
por: Prasopdee, Sattrachai, et al.
Publicado: (2023)

DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma
por: Lorenzo, Nevi, et al.
Publicado: (2021)

Essential updates 2021/2022: Update in surgical strategy for perihilar cholangiocarcinoma
por: Kawano, Fumihiro, et al.
Publicado: (2023)

Nutrition Assessment and Management in Patients with Cirrhosis and Cognitive Impairment: A Comprehensive Review of Literature
por: Faccioli, Jessica, et al.
Publicado: (2022)

Revisiting targeted therapy and immunotherapy for advanced cholangiocarcinoma
por: Du, Jiajia, et al.
Publicado: (2023)

Advances in molecular and cell therapy for immunotherapy of cholangiocarcinoma
por: Zhao, Li-ming, et al.
Publicado: (2023)

Ammonia and the Muscle: An Emerging Point of View on Hepatic Encephalopathy
por: Di Cola, Simone, et al.
Publicado: (2022)

Recent Advances in Understanding Cholangiocarcinoma
por: Kennedy, Lindsey, et al.
Publicado: (2017)

Recent advances in understanding cholangiocarcinoma
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_db0uphqrc1g6lqtka0e4t7mtsf